EP0680746A1 - Sunscreen composition - Google Patents

Sunscreen composition Download PDF

Info

Publication number
EP0680746A1
EP0680746A1 EP95810297A EP95810297A EP0680746A1 EP 0680746 A1 EP0680746 A1 EP 0680746A1 EP 95810297 A EP95810297 A EP 95810297A EP 95810297 A EP95810297 A EP 95810297A EP 0680746 A1 EP0680746 A1 EP 0680746A1
Authority
EP
European Patent Office
Prior art keywords
light stabilizer
oil
stabilizer according
lipid
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP95810297A
Other languages
German (de)
French (fr)
Other versions
EP0680746B1 (en
Inventor
Rolf Dieter Juch
Gerd Birrenbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spirig Pharma AG
Original Assignee
Spirig AG Pharmazeutische Praeparate
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spirig AG Pharmazeutische Praeparate filed Critical Spirig AG Pharmazeutische Praeparate
Publication of EP0680746A1 publication Critical patent/EP0680746A1/en
Application granted granted Critical
Publication of EP0680746B1 publication Critical patent/EP0680746B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm

Definitions

  • the present invention relates to a light stabilizer. This is to be understood as a means that offers protection against sun rays or other UVA and / or UVB emitting light sources.
  • preservatives and stabilizers must be added, which can have an adverse effect on skin-sensitive and allergic users.
  • the emulsifiers used together with sun exposure can cause allergic reactions, such as, for example so-called Stahl acne.
  • the non-toxicity, biological acceptance, lack of penetration and high cosmetic quality speak in favor of the use of pigments in light stabilizers.
  • an anhydrous light stabilizer can be obtained using an ultrafine pigment such as TiO2 or ZnO, and a lipogel containing a combination of at least two selected lipids as a vehicle for a cosmetically acceptable and stable preparation, the SPF of the type and amount of the pigment used, but also on the type and amount of the combination of at least two selected lipids.
  • a composition of the type mentioned above can contain up to 30%, but preferably not more than 10%, of pigments and does not require any chemical filter substances, emulsifiers, preservatives or perfume.
  • concentration of pigments can also be considerably lower, provided that you do not want to actually manufacture a sun block, but rather a tanning product that should not keep the sun's rays completely away from the skin.
  • adding a combination of at least two selected lipids can Surprisingly high SPF can be achieved in vitro and in vivo without the addition of a chemically active UV absorber.
  • composition according to the invention is water-resistant.
  • Ultrafine pigment in a grain size range of ⁇ 100 nm is preferably used, which ensures transparency on the skin despite high concentration. The agglomeration tendency of these small particles is prevented by the composition according to the invention.
  • the pigments are available on the market. So you can as ultra-fine TiO2 e.g. Use Tioveil from Tioxide Chemicals Limited, UK, or Tri-K from Tri-K Industries, Inc., Emerson N.J., P25 from Degussa, MT150W from Teikoku Kako Co.Ltd., TiO2 from Bayer or UV-Titan from Kemira, Finland.
  • ultra-fine TiO2 e.g. Use Tioveil from Tioxide Chemicals Limited, UK, or Tri-K from Tri-K Industries, Inc., Emerson N.J., P25 from Degussa, MT150W from Teikoku Kako Co.Ltd., TiO2 from Bayer or UV-Titan from Kemira, Finland.
  • TiO2 or ZnO alone or in combination, with TiO2 being preferred.
  • the concentration of up to 30% of pigments can not only achieve an absolute sun protection factor, but also a balanced UVA and UVB protection, which is just as important for the quality of a light protection agent.
  • the factor stated on the sun protection products relates to the protection against UVB radiation, which for is responsible for the sunburn.
  • the SPF indicates how many times longer you can be exposed to the radiation before the first signs of sunburn develop.
  • a sunscreen with SPF 20 thus means that an individual can be exposed to the sun, for example, 20 times longer than in an unprotected state.
  • UVA ultraviolet A
  • the ratio of the total light reflection / light absorption of the UVA range to the UVB range is determined as the quotient under the area of the UVA protection curve of a light stabilizer by the area of the UVB protection curve.
  • a ratio of 0.2-0.4 is rated as moderate, 0.4-0.6 as good, 0.6-0.8 as very good and> 0.8 as maximum.
  • the ratio of the light stabilizer according to the invention is in the range of 0.6-0.8 and can therefore be classified as very good.
  • a framework that contains a combination of at least two selected lipids, namely a first lipid and a second co-lipid, at least one consistency agent, at least one cosmetically acceptable volatile carrier and optionally at least one suspending agent.
  • the task of the cosmetically acceptable volatile carrier is to increase the viscosity of the sunscreen reduce the spreading and spreading of the sunscreen on the skin and thus reduce the required layer thickness of pigment and combination of at least two lipids.
  • the carrier does not have its own SPF and evaporates quickly on the skin after application.
  • first lipid, second co-lipid and volatile carrier increases the sun protection factor, improves the stability of the light protection agent, avoids the breading effect and achieves the necessary cosmetic acceptance.
  • the first lipid are fatty acid esters such as ethylhexyl palmitate, octyl stearate, diisopropyl sebacate, C12-C15 alcohol benzoates, ethylhexyl stearate, diisopropyl dimerate, myristyl lactate or isopropyl myristate, or mixtures thereof.
  • fatty acid esters such as ethylhexyl palmitate, octyl stearate, diisopropyl sebacate, C12-C15 alcohol benzoates, ethylhexyl stearate, diisopropyl dimerate, myristyl lactate or isopropyl myristate, or mixtures thereof.
  • co-lipid are polysiloxane-polyalkylene copolymers, vegetable oils and oil fractions obtained therefrom, such as jojoba oil, sunflower oil, almond oil, thistle oil, passion flower oil, shea butter, soybean oil, wheat germ oil, olive oil, C8 -C10 triglycerides or mixtures thereof.
  • vegetable oils and oil fractions obtained therefrom such as jojoba oil, sunflower oil, almond oil, thistle oil, passion flower oil, shea butter, soybean oil, wheat germ oil, olive oil, C8 -C10 triglycerides or mixtures thereof.
  • Suitable as cosmetically acceptable volatile carriers are mineral spirits, volatile silicones, e.g. Cyclometicone, dimeticone, phenyldimeticone, cyclohexane, ethyl propionate, methyl ethyl ketone, ethyl glycol methyl ether, butyl acetate, trichloroethane, Shellsol T, ethyl lactate or mixtures thereof.
  • volatile silicones e.g. Cyclometicone, dimeticone, phenyldimeticone, cyclohexane, ethyl propionate, methyl ethyl ketone, ethyl glycol methyl ether, butyl acetate, trichloroethane, Shellsol T, ethyl lactate or mixtures thereof.
  • Suitable consistency agents are wax-like substances such as ozokerite, carnabewax, beeswax, hydroxyoctacosanyl hydroxystearate, paraffin wax, glyceryl tribehenate, C18-C36 glycolic acid, partially hydrogenated C14-C2geber Glycerides, zinc stearate, aluminum stearate or calcium stearate or mixtures thereof.
  • Suitable suspension aids preventing particle sinking are e.g. Lecithin or colloidal silica or a mixture thereof.
  • an antioxidant such as Add dl-alpha-tocopherol, butylated hydroxyanisole or ascorbyl palmitate.
  • the light stabilizer according to the invention preferably contains: 1-30%, preferably 5-15%, particularly preferably approx. 10% of an inorganic pigment, such as ultrafine TiO2 or ZnO, or a mixture thereof, 5-30%, preferably 10-25%, particularly preferably approximately 19% of a first lipid or a mixture thereof, 1-20%, preferably 5-15%, particularly preferably approx. 10% of a second co-lipid or a mixture thereof, 1-80%, preferably 30-60%, particularly preferably approx. 53% of a cosmetically acceptable volatile carrier or a mixture thereof, 1-20%, preferably 3-15%, particularly preferably approx.
  • an inorganic pigment such as ultrafine TiO2 or ZnO
  • an inorganic pigment such as ultrafine TiO2 or ZnO
  • the light stabilizer according to the invention preferably contains: 1-30%, preferably 5-15%, particularly preferably approx. 10% of an inorganic pigment, such as ultrafine TiO2 or ZnO, or a mixture thereof, 5-30%
  • a consistency agent or a mixture thereof 0-10%, preferably 1-7%, particularly preferably about 2% of a suspending aid or a mixture thereof, 0-5%, preferably 0.05-3%, particularly preferably about 0.1% of an antioxidant or a mixture thereof.
  • the light stabilizer can have a lotus-like or cream-like consistency, but is an O / W or W / O emulsion because of the absence of water.
  • a light protection agent of creamy consistency with the following composition is produced: Titanium dioxide ultra fine 10.0 g Ethylhexyl palmitate 19.0 g Passion flower oil 10.0 g Cyclometicone 41.0 g Dimeticon 10.0 g Carnauba wax 10.0 g
  • a light protection agent of creamy consistency with the following composition is produced:
  • a light protection agent of creamy consistency with the following composition is produced: Titanium dioxide ultra fine 10.0 g C12-C15 alcohol benzoate 15.0 g Jojoba oil 10.0 g Cyclometicone 45.0 g Dimeticon 10.0 g Ozokerite 5.0 g partially hydrogenated C14-C20 glycerides 5.0 g
  • a light stabilizer with a lotus-like consistency is produced with the following composition: Titanium dioxide ultra fine 10.0 g Ethylhexyl palmitate 19.0 g almond oil 10.0 g Cyclometicone 42.9 g Dimeticon 10.0 g Carnauba wax 3.0 g partially hydrogenated C14-C20 glycerides 3.0 g colloidal silicon dioxide 2.0 g dl-alpha tocopherol 0.1 g
  • a light stabilizer with a lotus-like consistency is produced with the following composition: Titanium dioxide ultra fine 8.0 g Zinc oxide ultra fine 2.0 g Diisopropyl sebacate 19.0 g Safflower oil 10.0 g Dimeticon 10.0 g Carnauba wax 3.0 g partially hydrogenated C14-C20 glycerides 3.0 g colloidal silicon dioxide 2.0 g dl-alpha tocopherol 0.1 g
  • a light stabilizer with a lotus-like consistency is produced with the following composition: Titanium dioxide ultra fine 10.0 g Zinc oxide ultra fine 5.0 g Ethylhexyl stearate 25.0 g Wheat germ oil 10.0 g Cyclometicone 39.5 g Hydroxyoctacosanyl hydroxystearate 5.0 g partially hydrogenated C14-C20 glycerides 2.0 g colloidal silicon dioxide 3.0 g Lecithin 0.5 g
  • the sun protection factors of various combinations of first lipid and second co-lipid with titanium dioxide were determined in an in vitro experiment using the Diffey method (Lit .: A new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum, BL Diffey and J. Robson, J. Soc. Cosmet. Chem., 40, 127-133 [May / June 1989]).
  • the co-lipid is shown on the vertical axis of the various diagrams (1-5).
  • a different first lipid is used for each diagram. In each case a combination of 10% TiO2, 15% first lipid, 10% second co-lipid, 45% cyclometicone, 10% dimeticone and 3% carnauba wax and C14-C20 glycerides was used. It can be seen from this that the sun protection factor, depending on the combination of the first lipid and second co-lipid, has considerable differences with a constant amount of TiO 2.
  • Example 4 At the Laboratoire deInstituts sur les Tumeurs de la Peau Humaine in Paris, the light stabilizer according to Example 4 was tested in vivo on 20 subjects.
  • Table 1 shows the high measured SPF of the individual test subjects.
  • the water resistance of the light stabilizer according to Example 4 was measured in 10 subjects at the Laboratoire deInstituts sur les Tumeurs de la Peau Humaine in Paris.
  • the test area on the back of the test subjects was 100 cm2.
  • the SPF was measured before and after swimming (2x20 min) in a whirlpool in 32 ° C warm water.
  • Table 2 shows the high measured SPF before and after swimming.
  • the very good water resistance of the light stabilizer according to the invention is evident from the very low reduction in SPF after swimming.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Sunscreen compsns. contain inorganic pigment(s) and a lipogel (term not defined) as carrier. A specifically claimed compsn. comprises 10% ultrafine TiO2, 19% ethylhexyl palmitate, 10% almond oil, 42.9% cyclomethicone, 10% dimethicone, 3% carnauba wax, 3% partially hydrogenated 14-20C glycerides, 2% colloidal silica and 0.1% di- alpha -tocopherol.

Description

Die vorliegende Erfindung betrifft ein Lichtschutzmittel. Darunter soll ein Mittel verstanden werden, das Schutz gegen Sonnenstrahlen oder andere UVA und/oder UVB emittierende Lichtquellen bietet.The present invention relates to a light stabilizer. This is to be understood as a means that offers protection against sun rays or other UVA and / or UVB emitting light sources.

Bisher werden meist chemisch wirkende UV-Strahlen absorbierende Verbindungen in Sonnenschutzmitteln verwendet. Insbesondere werden Paraaminobenzoate (PABA-Derivate), Salicylate, Zimtsäureester und Benzophenone in in solche Mittel eingearbeitet. Da diese Verbindungen vor allem auch allergische Wirkungen hervorrufen können, ist ihre qualitative und quantitative Zusammensetzung von der FDA und in EC-Richtlinien vorgeschrieben. Will man einen höheren Lichtschutzfaktor (=LSF) erreichen, d.h. eine höhere Sonnenschutzwirkung des Präparats, ist dies häufig nicht möglich, ohne die vorgegebenen Grenzwerte zu überschreiten.So far, chemically acting compounds absorbing UV rays have been used in sunscreens. In particular, paraaminobenzoates (PABA derivatives), salicylates, cinnamic acid esters and benzophenones are incorporated into such agents. Since these compounds can also cause allergic effects, their qualitative and quantitative composition is prescribed by the FDA and in EC guidelines. If you want to achieve a higher sun protection factor (= SPF), i.e. a higher sun protection effect of the preparation, this is often not possible without exceeding the specified limit values.

Ein Ausweg aus diesem Dilemma besteht darin, dass man physikalisch wirkende UV-Strahlenblocker anstelle der erwähnten organisch-chemischen Verbindungen verwendet. Geeignete Beispiele dafür sind ZnO und TiO₂, die jeweils - wie dies auch für die chemisch wirkenden UV-Strahlen absorbierenden organisch-chemischen Verbindungen gilt - als O/W- oder - insbesondere für wasserfeste Emulsionen W/O-Emulsionen formuliert werden.One way out of this dilemma is to use physically effective UV radiation blockers instead of the organic-chemical compounds mentioned. Suitable examples of this are ZnO and TiO₂, each of which - as is also true for the chemically active UV-absorbing organic-chemical compounds - are formulated as O / W or - in particular for waterproof emulsions W / O emulsions.

Fett und Wasser bilden für Mikroorganismen ideale Wachstumsbedingungen. Um die Emulsionen sicher zu konservieren, müssen demzufolge Konservierungsmittel und Stabilisatoren zugesetzt werden, was sich für hautempfindliche und allergisch reagierende Anwender ungünstig auswirken kann. Zudem können die verwendeten Emulgatoren zusammen mit der Sonneneinstrahlung allergische Reaktionen, wie z.B. die sogenannte Mallorca-Akne, hervorrufen. Für den Einsatz von Pigmenten in Lichtschutzmitteln sprechen dagegen deren Ungiftigkeit, biologische Akzeptanz, fehlendes Penetrationsvermögen und hohe kosmetische Qualität.Fat and water form ideal growth conditions for microorganisms. In order to preserve the emulsions safely, preservatives and stabilizers must be added, which can have an adverse effect on skin-sensitive and allergic users. In addition, the emulsifiers used together with sun exposure can cause allergic reactions, such as, for example so-called Mallorca acne. On the other hand, the non-toxicity, biological acceptance, lack of penetration and high cosmetic quality speak in favor of the use of pigments in light stabilizers.

Gemäss dem Stand der Technik ist es allerdings praktisch unmöglich, insbesondere TiO₂ in Konzentrationen von mehr als 5 % der Zusammensetzung kosmetisch akzeptabel zu verarbeiten, was die Höhe des Lichtschutzfaktors beschränkt; denn je geringer die Konzentration an Pigment ist, desto niedriger ist auch der LSF. Deshalb werden Pigmente überwiegend mit chemisch wirkenden UV-Absorbern kombiniert, um einen deutlichen LSF zu erhalten.According to the prior art, however, it is practically impossible to process in particular TiO₂ in concentrations of more than 5% of the composition in a cosmetically acceptable manner, which limits the level of the sun protection factor; because the lower the concentration of pigment, the lower the SPF. For this reason, pigments are predominantly combined with chemically acting UV absorbers in order to obtain a clear SPF.

Es wurde nun überraschend gefunden, dass man ein wasserfreies Lichtschutzmittel unter Verwendung eines ultrafeinen Pigments, wie TiO₂ oder ZnO, und einem Lipogel, enthaltend eine Kombination von mindestens zwei ausgewählten Lipiden, als Vehikel für ein kosmetisch akzeptables und stabiles Präparat erhalten kann, dessen LSF von der Art und Menge des verwendeten Pigments, aber auch von der Art und Menge der verwendeten Kombination von mindestens zwei ausgewählten Lipiden abhängig ist.It has now surprisingly been found that an anhydrous light stabilizer can be obtained using an ultrafine pigment such as TiO₂ or ZnO, and a lipogel containing a combination of at least two selected lipids as a vehicle for a cosmetically acceptable and stable preparation, the SPF of the type and amount of the pigment used, but also on the type and amount of the combination of at least two selected lipids.

Eine Zusammensetzung der oben erwähnten Art kann bis zu 30 %, vorzugsweise aber nicht mehr als 10 %, an Pigmenten enthalten und benötigt dazu weder chemische Filtersubstanzen noch Emulgatoren, Konservierungsmittel oder Parfum. Selbstverständlich kann die Konzentration an Pigmenten auch beträchtlich tiefer sein, sofern man keinen eigentlichen Sonnenblocker, sondern eher ein Bräunungsprodukt, das die Sonnenstrahlen nicht vollkommen von der Haut fernhalten soll, herstellen will.A composition of the type mentioned above can contain up to 30%, but preferably not more than 10%, of pigments and does not require any chemical filter substances, emulsifiers, preservatives or perfume. Of course, the concentration of pigments can also be considerably lower, provided that you do not want to actually manufacture a sun block, but rather a tanning product that should not keep the sun's rays completely away from the skin.

Trotz der - im Verhältnis zum erreichten LSF - geringen Menge an verwendeten Pigmenten kann durch Zusatz einer Kombination von mindestens zwei ausgewählten Lipiden ein überraschend hoher LSF in vitro und in vivo erzielt werden, ohne dass zusätzlich ein chemisch wirkender UV-Absorber zugesetzt wird.Despite the - in relation to the achieved SPF - small amount of pigments used, adding a combination of at least two selected lipids can Surprisingly high SPF can be achieved in vitro and in vivo without the addition of a chemically active UV absorber.

Ferner wird durch das neue Mittel der sogenannte Paniereffekt, d.h. das Anhaften z.B. von Sand am eingeriebenen Körper, vermieden. Zudem ist die erfindungsgemässe Zusammensetzung wasserbeständig.Furthermore, the so-called breading effect, i.e. clinging e.g. of sand on the rubbed body, avoided. In addition, the composition according to the invention is water-resistant.

Vorzugsweise wird ultrafeines Pigment in einem Korngrössenbereich von <100 nm verwendet, wodurch trotz hoher Konzentration die Transparenz auf der Haut gewährleistet wird. Die Agglomerationstendenz dieser kleinen Partikel wird durch die erfindungsgemässe Zusammensetzung verhindert.Ultrafine pigment in a grain size range of <100 nm is preferably used, which ensures transparency on the skin despite high concentration. The agglomeration tendency of these small particles is prevented by the composition according to the invention.

Die Pigmente sind auf dem Markt erhältlich. So kann man als ultrafeines TiO₂ z.B. Tioveil von Tioxide Chemicals Limited, UK, oder Tri-K von Tri-K Industries, Inc., Emerson N.J., P25 von Degussa, MT150W von Teikoku Kako Co.Ltd., TiO₂ von Bayer oder UV-Titan von Kemira, Finnland verwenden.The pigments are available on the market. So you can as ultra-fine TiO₂ e.g. Use Tioveil from Tioxide Chemicals Limited, UK, or Tri-K from Tri-K Industries, Inc., Emerson N.J., P25 from Degussa, MT150W from Teikoku Kako Co.Ltd., TiO₂ from Bayer or UV-Titan from Kemira, Finland.

Als ZnO kann man z.B. Z-Cote von Sunsmart Inc., USA verwenden.As a ZnO you can e.g. Use Z-Cote from Sunsmart Inc., USA.

Als Pigment kann man z.B. TiO₂ oder ZnO allein oder in Kombination miteinander benützen, wobei TiO₂ bevorzugt wird.As a pigment one can e.g. Use TiO₂ or ZnO alone or in combination, with TiO₂ being preferred.

Durch die Konzentration von bis zu 30% an Pigmenten kann nicht nur ein absoluter Lichtschutzfaktor, sondern auch ein ausgeglichener UVA- und UVB-Schutz erreicht werden, was für die Qualität eines Lichtschutzmittels von ebenso grosser Bedeutung ist.The concentration of up to 30% of pigments can not only achieve an absolute sun protection factor, but also a balanced UVA and UVB protection, which is just as important for the quality of a light protection agent.

Der auf den Sonnenschutzpräparaten angegebene Faktor bezieht sich auf den Schutz gegen UVB-Strahlung, welche für den Sonnenbrand verantwortlich ist. Der LSF gibt an, wievielmal länger man sich der Strahlung aussetzen kann, bis erste Anzeichen eines Sonnenbrandes entstehen. Ein Sonnenschutzmittel mit LSF 20 bedeutet somit, dass sich ein Individuum 20 mal länger als in ungeschütztem Zustand z.B. der Sonne aussetzen kann.The factor stated on the sun protection products relates to the protection against UVB radiation, which for is responsible for the sunburn. The SPF indicates how many times longer you can be exposed to the radiation before the first signs of sunburn develop. A sunscreen with SPF 20 thus means that an individual can be exposed to the sun, for example, 20 times longer than in an unprotected state.

Chronisch hohe UVA-Dosen sind hauptsächlich für die Hautalterung und die Krebsentstehung mitverantwortlich. Benützt man ein Sonnenschutzmittel nur mit hohem LSF für UVB-Strahlung, kann es vorkommen, dass die Haut zuviel UVA-Strahlung abbekommt, ohne dass dies sofort bemerkt wird. Deshalb sind Sonnenschutzmittel mit unausgewogenem Verhältnis zwischen UVA/UVB-Schutz zur Verhinderung von Langzeitschäden ungeeignet.Chronically high doses of UVA are mainly responsible for skin aging and the development of cancer. If you only use a sunscreen with a high SPF for UVB radiation, it can happen that the skin gets too much UVA radiation without this being noticed immediately. Sunscreens with an unbalanced ratio between UVA / UVB protection are therefore unsuitable for preventing long-term damage.

Das Verhältnis der gesamten Lichtreflexion/Lichtabsorption des UVA-Bereichs zum UVB-Bereich wird als Quotient unter der Fläche der UVA-Schutz-Kurve eines Lichtschutzmittels durch die Fläche der UVB-Schutzkurve bestimmt. Dabei wird ein Verhältnis von 0,2-0,4 als mässig, 0,4-0,6 als gut, 0,6-0,8 als sehr gut und >0,8 als maximal bewertet.The ratio of the total light reflection / light absorption of the UVA range to the UVB range is determined as the quotient under the area of the UVA protection curve of a light stabilizer by the area of the UVB protection curve. A ratio of 0.2-0.4 is rated as moderate, 0.4-0.6 as good, 0.6-0.8 as very good and> 0.8 as maximum.

Das Verhältnis des erfindungsgemässen Lichtschutzmittels bewegt sich im Bereich von 0,6-0,8 und ist deshalb als sehr gut einzustufen.The ratio of the light stabilizer according to the invention is in the range of 0.6-0.8 and can therefore be classified as very good.

Zur Herstellung eines Lipogels wird ein Gerüst benötigt, das eine Kombination von mindestens zwei ausgewählten Lipiden, nämlich von einem ersten Lipid und einem zweiten Co-Lipid, mindestens einem Konsistenzgeber, mindestens einem kosmetisch akzeptablen flüchtigen Träger und gegebenenfalls mindestens einem Suspendierhilfsmittel enthält.To produce a lipogel, a framework is required that contains a combination of at least two selected lipids, namely a first lipid and a second co-lipid, at least one consistency agent, at least one cosmetically acceptable volatile carrier and optionally at least one suspending agent.

Die Aufgabe des kosmetisch akzeptablen flüchtigen Trägers besteht darin, die Viskosität des Sonnenschutzmittels zu verringern, das Verstreichen und Verteilen des Sonnenschutzmittels auf der Haut zu verbessern und damit die benötigte Schichtdicke von Pigment und Kombination aus mindestens zwei Lipiden zu verringern. Hingegen besitzt der Träger keinen eigenen LSF und verflüchtigt sich nach Applikation rasch auf der Haut.The task of the cosmetically acceptable volatile carrier is to increase the viscosity of the sunscreen reduce the spreading and spreading of the sunscreen on the skin and thus reduce the required layer thickness of pigment and combination of at least two lipids. In contrast, the carrier does not have its own SPF and evaporates quickly on the skin after application.

Durch die Kombination erstes Lipid, zweites Co-Lipid und flüchtiger Träger wird der Lichtschutzfaktor erhöht, die Stabilität des Lichtschutzmittels verbessert, der Panierffekt vermieden und die notwendige kosmetische Akzeptanz erreicht.The combination of first lipid, second co-lipid and volatile carrier increases the sun protection factor, improves the stability of the light protection agent, avoids the breading effect and achieves the necessary cosmetic acceptance.

Als erstes Lipid eignen sich Fettsäureester, wie Ethylhexylpalmitat Octylstearat, Diisopropylsebacat, C₁₂-C₁₅ Alkoholbenzoate, Ethylhexylstearat, Diisopropyldimerat, Myristyllaktat oder Isopropylmyristat, oder Gemische davon.As the first lipid are fatty acid esters such as ethylhexyl palmitate, octyl stearate, diisopropyl sebacate, C₁₂-C₁₅ alcohol benzoates, ethylhexyl stearate, diisopropyl dimerate, myristyl lactate or isopropyl myristate, or mixtures thereof.

Als zweites Co-Lipid eignen sich Polysiloxan-Polyalkylen-Copolymere, Pflanzliche Öle und daraus gewonnene Ölfraktionen, wie Jojobaöl, Sonnenblumenöl, Mandelöl, -Distelöl, Passionsblumenöl, Sheabutter, Sojaöl, Weizenkeimöl, Olivenöl, C₈ -C₁₀ Triglyceride oder Gemische davon.As a second co-lipid are polysiloxane-polyalkylene copolymers, vegetable oils and oil fractions obtained therefrom, such as jojoba oil, sunflower oil, almond oil, thistle oil, passion flower oil, shea butter, soybean oil, wheat germ oil, olive oil, C₈ -C₁₀ triglycerides or mixtures thereof.

Als kosmetisch akzeptable flüchtige Träger eignen sich Wundbenzin, volatile Silikone, wie z.B. Cyclometicon, Dimeticon, Phenyldimeticon, Cyclohexan, Ethylpropionat, Methylethylketon, Ethylglykolmethylether, Butylacetat, Trichlorethan, Shellsol T, Ethyllactat oder Gemische davon.Suitable as cosmetically acceptable volatile carriers are mineral spirits, volatile silicones, e.g. Cyclometicone, dimeticone, phenyldimeticone, cyclohexane, ethyl propionate, methyl ethyl ketone, ethyl glycol methyl ether, butyl acetate, trichloroethane, Shellsol T, ethyl lactate or mixtures thereof.

Als Konsistenzgeber eignen sich wachsartige Substanzen, wie z.B. Ozokerit, Carnabauwachs, Bienenwachs, Hydroxyoctacosanyl Hydroxystearat, Paraffinwachs, Glyceryltribehenat, C₁₈-C₃₆ Glykolestersäuren, partiell hydrierte C₁₄-C₂₀ Glyceride, Zinkstearat, Aluminiumstearat oder Calciumstearat oder Gemische davon.Suitable consistency agents are wax-like substances such as ozokerite, carnabewax, beeswax, hydroxyoctacosanyl hydroxystearate, paraffin wax, glyceryl tribehenate, C₁₈-C₃₆ glycolic acid, partially hydrogenated C₁₄-C₂geber Glycerides, zinc stearate, aluminum stearate or calcium stearate or mixtures thereof.

Als das Absinken von Teilchen verhinderndes Suspendierhilfsmittel eignen sich z.B. Lecithin oder kolloidales Siliciumdioxid oder ein Gemisch davon.Suitable suspension aids preventing particle sinking are e.g. Lecithin or colloidal silica or a mixture thereof.

Bei Bedarf kann man ein Antioxidans, wie z.B. dl-alpha-Tocopherol, Butylhydroxyanisol oder Ascorbylpalmitat zugeben.If necessary, an antioxidant such as Add dl-alpha-tocopherol, butylated hydroxyanisole or ascorbyl palmitate.

Das erfindungsgemässe Lichtschutzmittel enthält bezogen auf sein Gesamtgewicht vorzugsweise:
1-30%, vorzugsweise 5-15%, besonders bevorzugt ca. 10% eines anorganischen Pigments, wie ultrafeines TiO₂ oder ZnO, oder eines Gemisches davon,
5-30%, vorzugsweise 10-25%, besonders bevorzugt ca. 19% eines ersten Lipids oder eines Gemisches davon,
1-20%, vorzugsweise 5-15%, besonders bevorzugt ca. 10% eines zweiten Co-Lipids oder eines Gemisches davon,
1-80%, vorzugsweise 30-60%, besonders bevorzugt ca. 53% eines kosmetisch akzeptablen flüchtigen Trägers oder eines Gemisches davon,
1-20%, vorzugsweise 3-15%, besonders bevorzugt ca. 6% eines Konsistenzgebers oder eines Gemisches davon,
0-10%, vorzugsweise 1-7%, besonders bevorzugt ca. 2% eines Suspendierhilfsmittels oder eines Gemisches davon,
0-5%, vorzugsweise 0,05-3%, besonders bevorzugt ca. 0,1% eines Antioxidans oder eines Gemisches davon.
Based on its total weight, the light stabilizer according to the invention preferably contains:
1-30%, preferably 5-15%, particularly preferably approx. 10% of an inorganic pigment, such as ultrafine TiO₂ or ZnO, or a mixture thereof,
5-30%, preferably 10-25%, particularly preferably approximately 19% of a first lipid or a mixture thereof,
1-20%, preferably 5-15%, particularly preferably approx. 10% of a second co-lipid or a mixture thereof,
1-80%, preferably 30-60%, particularly preferably approx. 53% of a cosmetically acceptable volatile carrier or a mixture thereof,
1-20%, preferably 3-15%, particularly preferably approx. 6% of a consistency agent or a mixture thereof,
0-10%, preferably 1-7%, particularly preferably about 2% of a suspending aid or a mixture thereof,
0-5%, preferably 0.05-3%, particularly preferably about 0.1% of an antioxidant or a mixture thereof.

Das Lichtschutzmittel kann je nach Zusammensetzung von lotioartiger oder crèmeartiger Konsistenz sein, ist aber wegen der Abwesenheit von Wasser nei eine O/W- oder W/O-Emulsion.Depending on the composition, the light stabilizer can have a lotus-like or cream-like consistency, but is an O / W or W / O emulsion because of the absence of water.

Die Erfindung wird im folgenden an Hand von Beispielen näher erläutert.The invention is explained in more detail below with the aid of examples.

Beispiel 1example 1

Es wird ein Lichtschutzmittel crèmeartiger Konsistenz folgender Zusammensetzung hergestellt: Titandioxid ultrafein 10,0 g Ethylhexylpalmitat 19,0 g Passionsblumenöl 10,0 g Cyclometicon 41,0 g Dimeticon 10,0 g Carnaubawachs 10,0 g A light protection agent of creamy consistency with the following composition is produced: Titanium dioxide ultra fine 10.0 g Ethylhexyl palmitate 19.0 g Passion flower oil 10.0 g Cyclometicone 41.0 g Dimeticon 10.0 g Carnauba wax 10.0 g

Alle Stoffe mit Ausnahme des Titandioxids und des flüchtigen Trägers werden zusammengegeben und auf 80°C erhitzt. Darauf wird der Pigmentanteil unter Rühren eingegeben und auf 40°C abgekühlt. Danach wird der flüchtige Träger unter Kühlen und Mischen zugefügt und das Gemisch auf 25°C abgekühlt.All substances with the exception of the titanium dioxide and the volatile carrier are combined and heated to 80 ° C. The pigment portion is then added with stirring and cooled to 40 ° C. The volatile carrier is then added with cooling and mixing and the mixture is cooled to 25 ° C.

Beispiel 2Example 2

Es wird ein Lichtschutzmittel crèmeartiger Konsistenz folgender Zusammensetzung hergestellt:

Figure imgb0001
Figure imgb0002
A light protection agent of creamy consistency with the following composition is produced:
Figure imgb0001
Figure imgb0002

Das Herstellungsverfahren wird analog zu dem im Beispiel 1 beschriebenen durchgeführt.The production process is carried out analogously to that described in Example 1.

Beispiel 3Example 3

Es wird ein Lichtschutzmittel crèmeartiger Konsistenz folgender Zusammensetzung hergestellt: Titandioxid ultrafein 10,0 g C₁₂-C₁₅ Alkoholbenzoat 15,0 g Jojobaöl 10,0 g Cyclometicon 45,0 g Dimeticon 10,0 g Ozokerit 5,0 g partiell hydrierte C₁₄-C₂₀ Glyceride 5,0 g A light protection agent of creamy consistency with the following composition is produced: Titanium dioxide ultra fine 10.0 g C₁₂-C₁₅ alcohol benzoate 15.0 g Jojoba oil 10.0 g Cyclometicone 45.0 g Dimeticon 10.0 g Ozokerite 5.0 g partially hydrogenated C₁₄-C₂₀ glycerides 5.0 g

Das Herstellungsverfahren wird analog zu dem im Beispiel 1 beschriebenen durchgeführt.The production process is carried out analogously to that described in Example 1.

Beispiel 4Example 4

Es wird ein Lichtschutzmittel lotioartiger Konsistenz folgender Zusammensetzung hergestellt: Titandioxid ultrafein 10,0 g Ethylhexylpalmitat 19,0 g Mandelöl 10,0 g Cyclometicon 42,9 g Dimeticon 10,0 g Carnaubawachs 3,0 g partiell hydrierte C₁₄-C₂₀ Glyceride 3,0 g kolloidales Siliciumdioxid 2,0 g dl-alpha-Tocopherol 0,1 g A light stabilizer with a lotus-like consistency is produced with the following composition: Titanium dioxide ultra fine 10.0 g Ethylhexyl palmitate 19.0 g almond oil 10.0 g Cyclometicone 42.9 g Dimeticon 10.0 g Carnauba wax 3.0 g partially hydrogenated C₁₄-C₂₀ glycerides 3.0 g colloidal silicon dioxide 2.0 g dl-alpha tocopherol 0.1 g

Das Herstellungsverfahren wird analog zu dem im Beispiel 1 beschriebenen durchgeführt.The production process is carried out analogously to that described in Example 1.

Beispiel 5Example 5

Es wird ein Lichtschutzmittel lotioartiger Konsistenz folgender Zusammensetzung hergestellt: Titandioxid ultrafein 8,0 g Zinkoxid ultrafein 2,0 g Diisopropylsebacat 19,0 g Distelöl 10,0 g Dimeticon 10,0 g Carnaubawachs 3,0 g partiell hydrierte C₁₄-C₂₀ Glyceride 3,0 g kolloidales Siliciumdioxid 2,0 g dl-alpha-Tocopherol 0,1 g A light stabilizer with a lotus-like consistency is produced with the following composition: Titanium dioxide ultra fine 8.0 g Zinc oxide ultra fine 2.0 g Diisopropyl sebacate 19.0 g Safflower oil 10.0 g Dimeticon 10.0 g Carnauba wax 3.0 g partially hydrogenated C₁₄-C₂₀ glycerides 3.0 g colloidal silicon dioxide 2.0 g dl-alpha tocopherol 0.1 g

Das Herstellungsverfahren wird analog zu dem im Beispiel 1 beschriebenen durchgeführt.The production process is carried out analogously to that described in Example 1.

Beispiel 6Example 6

Es wird ein Lichtschutzmittel lotioartiger Konsistenz folgender Zusammensetzung hergestellt: Titandioxid ultrafein 10,0 g Zinkoxid ultrafein 5,0 g Ethylhexylstearat 25,0 g Weizenkeimöl 10,0 g Cyclometicon 39,5 g Hydroxyoctacosanyl Hydroxystearat 5,0 g partiell hydrierte C₁₄-C₂₀ Glyceride 2,0 g kolloidales Siliciumdioxid 3,0 g Lecithin 0,5 g A light stabilizer with a lotus-like consistency is produced with the following composition: Titanium dioxide ultra fine 10.0 g Zinc oxide ultra fine 5.0 g Ethylhexyl stearate 25.0 g Wheat germ oil 10.0 g Cyclometicone 39.5 g Hydroxyoctacosanyl hydroxystearate 5.0 g partially hydrogenated C₁₄-C₂₀ glycerides 2.0 g colloidal silicon dioxide 3.0 g Lecithin 0.5 g

Das Herstellungsverfahren wird analog zu dem im Beispiel 1 beschriebenen durchgeführt.The production process is carried out analogously to that described in Example 1.

Beispiel 7Example 7

Es wurden die Lichtschutzfaktoren von verschiedenen Kombinationen von erstem Lipid und zweitem Co-Lipid mit Titandioxid in einem in vitro-Versuch nach der Methode von Diffey (Lit.: A new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum, B.L. Diffey and J. Robson, J. Soc. Cosmet. Chem., 40, 127-133 [May/June 1989]) untersucht. Das Co-Lipid ist auf der senkrechten Achse der verschiedenen Diagramme (1-5) eingezeichnet. Für jedes Diagramm wird ein anderes erstes Lipid verwendet. Verwendet wurde jeweils eine Kombination von 10% TiO₂, 15% erstem Lipid, 10% zweitem Co-Lipid, 45% Cyclometicon, 10% Dimeticon und je 3% Carnaubawachs und C₁₄-C₂₀ Glyceriden. Daraus wird ersichtlich, dass der Lichtschutzfaktor je nach Kombination des ersten Lipid und zweiten Co-Lipids bei gleichbleibender Menge TiO₂ beträchtliche Unterschiede aufweist.The sun protection factors of various combinations of first lipid and second co-lipid with titanium dioxide were determined in an in vitro experiment using the Diffey method (Lit .: A new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum, BL Diffey and J. Robson, J. Soc. Cosmet. Chem., 40, 127-133 [May / June 1989]). The co-lipid is shown on the vertical axis of the various diagrams (1-5). A different first lipid is used for each diagram. In each case a combination of 10% TiO₂, 15% first lipid, 10% second co-lipid, 45% cyclometicone, 10% dimeticone and 3% carnauba wax and C₁₄-C₂₀ glycerides was used. It can be seen from this that the sun protection factor, depending on the combination of the first lipid and second co-lipid, has considerable differences with a constant amount of TiO 2.

Beispiel 8Example 8

In einem in vitro Vergleichsversuch nach der Methode von Diffey wurden die Lichtschutzfaktoren des käuflichen Produkts NeutrogenaR mit Titandioxid als alleinigem Lichtschutzmittel mit der erfindungsgemässen Formulierung gemäss den Beispielen 2 und 4 verglichen. In Fig.1 werden die günstigen Lichtschutzfaktoren der erfindungsgemässen Formulierungen und das ausgeglichene Verhältnis des Schutzes gegenüber UVA- und UVB-Strahlen gegenüber dem Handelspräparat im in vitro-Test nach Diffey ersichtlich. Ein Ausmessen des Verhältnisses des nach Beispiel 4 hergestellten Sonnenschutzmittels ergibt ein Resultat von ca. 0,7, was als sehr gut bewertet wird.In an in vitro comparison test using the Diffey method, the light protection factors of the commercially available product Neutrogena R with titanium dioxide as the sole light protection agent were compared with the formulation according to the invention according to Examples 2 and 4. 1 shows the favorable sun protection factors of the formulations according to the invention and the balanced ratio of protection against UVA and UVB rays compared to the commercial preparation in the in vitro test according to Diffey. Measuring the ratio of the sunscreen produced according to Example 4 gives a result of approximately 0.7, which is rated as very good.

Beispiel 9Example 9

Am Laboratoire de Recherches sur les Tumeurs de la Peau Humaine in Paris wurde das Lichtschutzmittel nach Beispiel 4 in vivo an 20 Probanden geprüft. Die Bestimmung des LSF in vivo erfolgte nach einer FDA-Methode und Empfehlungen der CIE mit einer 150 Watt Xenon UV-Lampe und einem Robertson-Berger-Dosimeter zur Messung der Erythemschwellenzeit der Testpersonen (minimale erythemale Dosis für die geschützte resp. ungeschützte Haut = MED). In der Tabelle 1 werden die hohen gemessenen LSF der einzelnen Probanden ersichtlich.At the Laboratoire de Recherches sur les Tumeurs de la Peau Humaine in Paris, the light stabilizer according to Example 4 was tested in vivo on 20 subjects. The SPF was determined in vivo according to an FDA method and recommendations of the CIE with a 150 watt xenon UV lamp and a Robertson-Berger dosimeter for measuring the erythema threshold time of the test subjects (minimum erythemal dose for the protected or unprotected skin = MED ). Table 1 shows the high measured SPF of the individual test subjects.

Beispiel 10Example 10

Die Wasserresistenz des Lichtschutzmittels nach Beispiel 4 wurde am Laboratoire de Recherches sur les Tumeurs de la Peau Humaine in Paris an 10 Probanden gemessen. Die Testfläche auf dem Rücken der Probanden betrug 100 cm². Die Messung des LSF erfolgte vor und nach dem Schwimmen (2x20 min) in einem Whirlpool in 32°C warmem Wasser. In der Tabelle 2 werden die hohen gemessenen LSF vor und nach dem Schwimmen ersichtlich. Die sehr gute Wasserresistenz des erfindungsgemässen Lichtschutzmittels ist an der sehr geringen Reduktion des LSF nach dem Schwimmen ersichtlich.The water resistance of the light stabilizer according to Example 4 was measured in 10 subjects at the Laboratoire de Recherches sur les Tumeurs de la Peau Humaine in Paris. The test area on the back of the test subjects was 100 cm². The SPF was measured before and after swimming (2x20 min) in a whirlpool in 32 ° C warm water. Table 2 shows the high measured SPF before and after swimming. The very good water resistance of the light stabilizer according to the invention is evident from the very low reduction in SPF after swimming.

Claims (17)

Lichtschutzmittel, welches mindestens ein anorganisches Pigment, wie TiO₂ oder ZnO oder ein Gemisch davon, und ein Lipogel als Vehikel erhält.Light stabilizer which contains at least one inorganic pigment, such as TiO₂ or ZnO or a mixture thereof, and a lipogel as a vehicle. Lichtschutzmittel nach Patentanspruch 1, dadurch gekennzeichnet, dass es als Pigment TiO₂ enthält.Light stabilizer according to claim 1, characterized in that it contains TiO₂ as a pigment. Lichtschutzmittel nach Patentanspruch 1 oder 2, dadurch gekennzeichnet, dass die mittlere Korngrösse des ultrafeinen Pigments <100 nm liegt.Light stabilizer according to claim 1 or 2, characterized in that the average grain size of the ultrafine pigment is <100 nm. Lichtschutzmittel nach einem der Patentansprüch 1-3, dadurch gekennzeichnet, dass das Lichtschutzmittel einen Lichtschutzfaktor > 10 aufweist.Light protection agent according to one of the claims 1-3, characterized in that the light protection agent has a sun protection factor> 10. Lichtschutzmittel nach einem der Patentansprüche 1-4, dadurch gekennzeichnet, dass das Lichtschutzmittel bis zu 30%, vorzugsweise ca. 10%, Pigment enthält.Light stabilizer according to one of claims 1-4, characterized in that the light stabilizer contains up to 30%, preferably about 10%, pigment. Lichtschutzmittel nach einem der Patentansprüche 1-5, dadurch gekennzeichnet, dass das Lipogel ein Gemisch aus mindestens einem ersten Lipid und mindestens einem zweiten Co-Lipid oder einem Gemisch davon enthält.Light stabilizer according to one of claims 1-5, characterized in that the lipogel contains a mixture of at least a first lipid and at least a second co-lipid or a mixture thereof. Lichtschutzmittel nach Patentanspruch 6, dadurch gekennzeichnet, dass das Lipogel mindestens einen kosmetisch akzeptablen flüchtigen Träger und/oder mindestens einen Konsistenzgeber enthält.Light stabilizer according to claim 6, characterized in that the lipogel contains at least one cosmetically acceptable volatile carrier and / or at least one consistency agent. Lichtschutzmittel nach einem der Patentansprüche 1-7, dadurch gekennzeichnet, dass das erste Lipid 1-30%, vorzugsweise 5-15% des Lichtschutzmittels ausmacht.Light stabilizer according to one of claims 1-7, characterized in that the first lipid makes up 1-30%, preferably 5-15% of the light stabilizer. Lichtschutzmittel nach einem der Patentansprüche 1-8, dadurch gekennzeichnet, dass das zweite Co-Lipid 1-20%, vorzugsweise 5-15% des Lichtschutzmittels ausmacht.Light stabilizer according to one of claims 1-8, characterized in that the second co-lipid makes up 1-20%, preferably 5-15%, of the light stabilizer. Lichtschutzmittel nach einem der Patentansprüche 1-9, dadurch gekennzeichnet, dass der kosmetisch akzeptable flüchtige Träger 1-80%, vorzugsweise 30-60% des Lichtschutzmittels ausmacht.Light stabilizer according to one of claims 1-9, characterized in that the cosmetically acceptable volatile carrier makes up 1-80%, preferably 30-60%, of the light stabilizer. Lichtschutzmittel nach einem der Patentansprüche 1-10, dadurch gekennzeichnet, dass der Konsistenzgeber 1-20%, vorzugsweise 3-15% des Lichtschutzmittels ausmacht.Light stabilizer according to one of the claims 1-10, characterized in that the consistency agent makes up 1-20%, preferably 3-15%, of the light stabilizer. Lichtschutzmittel nach einem der Patentansprüche 1-11, dadurch gekennzeichnet, dass das Lichtschutzmittel mindestens ein Suspendierhilfsmittel und/oder ein Antioxidans enthält.Light stabilizer according to one of claims 1-11, characterized in that the light stabilizer contains at least one suspending agent and / or an antioxidant. Lichtschutzmittel nach einem der Patentansprüche 1-10, dadurch gekennzeichnet, dass das Lichtschutzmittel als als erstes Lipid Fettsäureester, vorzugsweise Ethylhexylpalmitat, Octylstearat, Diisopropylsebacat, C₁₂-C₁₅ Alkoholbenzoate, Ethylhexylstearat, Diisopropyldimerat, Myristyllaktat oder Isopropylmyristat, oder Gemische davon, und als zweites Co-Lipid Polysiloxan-Polyalkylen-Copolymere, pflanzliche Öle und daraus gewonnene Ölfraktionen, vorzugsweise Jojobaöl, Sonnenblumenöl, Mandelöl, Distelöl, Passionsblumenöl, Sheabutter, Sojaöl, Weizenkeimöl, Olivenöl oder C₈-C₁₀ Triglyceride enthält.Light stabilizer according to one of the claims 1-10, characterized in that the light stabilizer as the first lipid is fatty acid ester, preferably ethylhexyl palmitate, octyl stearate, diisopropyl sebacate, C₁₂-C₁₅ alcohol benzoate, ethylhexyl stearate, diisopropyl dimerate, myristyl lactate or isopropyl myristate, or as a co-mixed myristate, or as a mixture of co-mixtures, or Contains lipid polysiloxane-polyalkylene copolymers, vegetable oils and oil fractions obtained therefrom, preferably jojoba oil, sunflower oil, almond oil, safflower oil, passion flower oil, shea butter, soybean oil, wheat germ oil, olive oil or C₈-C₁₀ triglycerides. Lichtschutzmittel nach einem der Patentansprüche 1-13, dadurch gekennzeichnet, dass das Lichtschutzmittel als kosmetisch akzeptablen flüchtigen Träger Wundbenzin, volatile Silikone, wie z.B. Cyclometicon, Dimeticon, Phenyldimeticon, Cyclohexan, Ethylpropionat, Methylethylketon, Ethylglykolmethylether, Butylacetat, Trichlorethan, Shellsol T, Ethyllactat oder Gemische davon enthält.Light stabilizer according to one of the claims 1-13, characterized in that the light stabilizer as a cosmetically acceptable volatile carrier, mineral spirits, volatile silicones such as cyclometicone, dimeticone, phenyldimeticone, cyclohexane, ethyl propionate, methyl ethyl ketone, ethyl glycol methyl ether, butyl acetate, Trichloroethane, Shellsol T, ethyl lactate or mixtures thereof contains. Lichtschutzmittel nach einem der Patentansprüche 1-14, dadurch gekennzeichnet, dass das Lichtschutzmittel als Konsistenzgeber wachsartige Substanzen, vorzugsweise Ozokerit, Carnabauwachs, Bienenwachs, Hydroxyoctacosanyl Hydroxystearat, Paraffinwachs, Glyceryltribehenat, C₁₈-C₃₆ Glykolestersäuren, partiell hydrierte C₁₄-C₂₀ Glyceride, Zinkstearat, Aluminiumstearat oder Calciumstearat oder Gemische davon enthält.Light stabilizer according to one of claims 1-14, characterized in that the light stabilizer as a consistency enhancer wax-like substances, preferably ozokerite, carnabewax, beeswax, hydroxyoctacosanyl hydroxystearate, paraffin wax, glyceryl tribehenate, C₁₈-C₃₆ glycol ester acids, partially hydrogenated C₁₄-C₂₀ glycerides, zinc stearate or zinc stearate Contains calcium stearate or mixtures thereof. Lichtschutzmittel nach einem der Patentansprüche 1-15, dadurch gekennzeichnet, dass das Lichtschutzmittel als Suspendierhilfsmittel Lecithin oder kolloidales Siliciumdioxid oder ein Gemisch davon und/oder als Antioxidans dl-alpha-Tocopherol, Butylhydroxyanisol oder Ascorbylpalmitat oder ein Gemisch davon enthält.Light stabilizer according to one of Claims 1-15, characterized in that the light stabilizer contains lecithin or colloidal silicon dioxide or a mixture thereof as a suspending aid and / or dl-alpha-tocopherol, butylated hydroxyanisole or ascorbyl palmitate or a mixture thereof as an antioxidant. Lichtschutzmittel nach einem der Patentansprüche 1-16, dadurch gekennzeichnet, dass das Lichtschutzmittel 10% Titandioxid ultrafein, 19% Ethylhexylpalmitat, 10% Mandelöl, 42,9% Cyclometicon, 10% Dimeticon, 3% Carnaubawachs, 3% partiell hydrierte C₁ ₄-C₂₀ Glyceride, 2% kolloidales Siliciumdioxid und 0,1% dl-alpha-Tocopherol enthält.Light stabilizer according to one of claims 1-16, characterized in that the light stabilizer 10% titanium dioxide ultrafine, 19% ethylhexyl palmitate, 10% almond oil, 42.9% cyclometicone, 10% dimeticone, 3% carnauba wax, 3% partially hydrogenated C₁ ₄-C₂₀ Contains glycerides, 2% colloidal silicon dioxide and 0.1% dl-alpha-tocopherol.
EP95810297A 1994-05-04 1995-05-04 Sunscreen composition Expired - Lifetime EP0680746B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH139294 1994-05-04
CH1392/94 1994-05-04
CH139294 1994-05-04

Publications (2)

Publication Number Publication Date
EP0680746A1 true EP0680746A1 (en) 1995-11-08
EP0680746B1 EP0680746B1 (en) 2001-10-24

Family

ID=4209360

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95810297A Expired - Lifetime EP0680746B1 (en) 1994-05-04 1995-05-04 Sunscreen composition

Country Status (3)

Country Link
EP (1) EP0680746B1 (en)
AT (1) ATE207340T1 (en)
DE (1) DE59509732D1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0801943A2 (en) * 1996-04-17 1997-10-22 Beiersdorf Aktiengesellschaft Cosmetic and dermatological photoprotective compositions containing a triazine derivative and alkyl and/or dialkylesters of alpha, omega-alkanedicarboxylic acid
WO1998042300A1 (en) * 1997-03-25 1998-10-01 Beiersdorf Ag Emulsifier-free finely dispersed systems of the water-in-oil type
KR100301079B1 (en) * 1996-12-30 2001-11-05 성재갑 Silicone Emulsifying Gel Foundation Composition without Surfactants
US6391321B1 (en) 1998-09-18 2002-05-21 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
US6410035B1 (en) 1998-09-18 2002-06-25 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
US6579529B2 (en) 1998-09-18 2003-06-17 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
US6582707B2 (en) 1998-09-18 2003-06-24 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
US6709662B1 (en) 1998-09-18 2004-03-23 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
US6838088B2 (en) 1998-09-18 2005-01-04 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water- and water-in-oil- type
DE102004047283A1 (en) * 2004-09-27 2006-04-13 Beiersdorf Ag O / W emulsions with inorganic UV photoprotective pigments
WO2013076075A3 (en) * 2011-11-23 2013-09-26 Basf Se Use of oleogels in uv absorber compositions

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695452A (en) * 1984-10-10 1987-09-22 Gannis Peter M Cosmetic stick
GB2206282A (en) * 1987-06-23 1989-01-05 Neutrogena Corp Topical composition for protecting against solar radiation
FR2646346A1 (en) 1989-04-26 1990-11-02 Thorel Jean Composition for the topical deposition of a permeable and light-reflecting continuous film
EP0433086A1 (en) * 1989-12-15 1991-06-19 JOHNSON &amp; JOHNSON CONSUMER PRODUCTS, INC. Sunscreen compositions
EP0456460A2 (en) * 1990-05-10 1991-11-13 Unilever Plc Cosmetic composition
WO1992013517A1 (en) * 1991-02-05 1992-08-20 Sun Smart, Inc. Visibly transparent uv sunblock agents and methods of making same
EP0535971A1 (en) 1991-10-04 1993-04-07 Tioxide Specialties Limited Oil dispersions of zinc oxide
WO1993011742A1 (en) * 1991-12-12 1993-06-24 The Boots Company Plc Sunscreen compositions
EP0559320A2 (en) * 1992-02-29 1993-09-08 Tioxide Specialties Limited Water-in-oil emulsions

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695452A (en) * 1984-10-10 1987-09-22 Gannis Peter M Cosmetic stick
GB2206282A (en) * 1987-06-23 1989-01-05 Neutrogena Corp Topical composition for protecting against solar radiation
FR2646346A1 (en) 1989-04-26 1990-11-02 Thorel Jean Composition for the topical deposition of a permeable and light-reflecting continuous film
EP0433086A1 (en) * 1989-12-15 1991-06-19 JOHNSON &amp; JOHNSON CONSUMER PRODUCTS, INC. Sunscreen compositions
EP0456460A2 (en) * 1990-05-10 1991-11-13 Unilever Plc Cosmetic composition
WO1992013517A1 (en) * 1991-02-05 1992-08-20 Sun Smart, Inc. Visibly transparent uv sunblock agents and methods of making same
EP0535971A1 (en) 1991-10-04 1993-04-07 Tioxide Specialties Limited Oil dispersions of zinc oxide
WO1993011742A1 (en) * 1991-12-12 1993-06-24 The Boots Company Plc Sunscreen compositions
EP0559320A2 (en) * 1992-02-29 1993-09-08 Tioxide Specialties Limited Water-in-oil emulsions

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0801943A3 (en) * 1996-04-17 2001-10-31 Beiersdorf Aktiengesellschaft Cosmetic and dermatological photoprotective compositions containing a triazine derivative and alkyl and/or dialkylesters of alpha, omega-alkanedicarboxylic acid
EP0801943A2 (en) * 1996-04-17 1997-10-22 Beiersdorf Aktiengesellschaft Cosmetic and dermatological photoprotective compositions containing a triazine derivative and alkyl and/or dialkylesters of alpha, omega-alkanedicarboxylic acid
KR100301079B1 (en) * 1996-12-30 2001-11-05 성재갑 Silicone Emulsifying Gel Foundation Composition without Surfactants
US6803048B2 (en) 1997-03-25 2004-10-12 Beiersdorf Ag Emulsifier-free finely dispersed systems of the water-in-oil type
US6558683B2 (en) 1997-03-25 2003-05-06 Beiersdorf Ag Emulsifier-free finely dispersed systems of the oil-in-water type
US6379680B2 (en) 1997-03-25 2002-04-30 Beiersdorf Ag Emulsifier-free finely dispersed systems of the water-in-oil type
WO1998042300A1 (en) * 1997-03-25 1998-10-01 Beiersdorf Ag Emulsifier-free finely dispersed systems of the water-in-oil type
WO1998042301A1 (en) * 1997-03-25 1998-10-01 Beiersdorf Ag Emulsifier-free finely dispersed systems of the water-in-oil type
US6440399B1 (en) 1997-03-25 2002-08-27 Beiersdorf Ag Emulsifier-free finely dispersed systems of the water-in-oil type
US6692755B2 (en) 1998-09-18 2004-02-17 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
US6579529B2 (en) 1998-09-18 2003-06-17 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
US6582707B2 (en) 1998-09-18 2003-06-24 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
US6410035B1 (en) 1998-09-18 2002-06-25 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
US6709662B1 (en) 1998-09-18 2004-03-23 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
US6767547B2 (en) 1998-09-18 2004-07-27 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
US6391321B1 (en) 1998-09-18 2002-05-21 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
US6803049B2 (en) 1998-09-18 2004-10-12 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
US6838088B2 (en) 1998-09-18 2005-01-04 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water- and water-in-oil- type
DE102004047283A1 (en) * 2004-09-27 2006-04-13 Beiersdorf Ag O / W emulsions with inorganic UV photoprotective pigments
WO2013076075A3 (en) * 2011-11-23 2013-09-26 Basf Se Use of oleogels in uv absorber compositions

Also Published As

Publication number Publication date
EP0680746B1 (en) 2001-10-24
DE59509732D1 (en) 2001-11-29
ATE207340T1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
EP0683662B1 (en) Waterproof cosmetic or dermatological photoprotective preparations
EP0683661B1 (en) Cosmetic and dermatological photoprotective formulations containing inorganic micro-pigments
DE69632255T3 (en) SUNSCREEN
DE69433131T2 (en) TITANIUM DIOXIDE DISPERSES, COSMETIC PREPARATIONS AND METHOD FOR THEIR USE
DE4429468C2 (en) Use of hydrophobized anorganic pigments to maintain the skin&#39;s urocanic acid status during bathing
EP0898955A2 (en) Sunscreen agent showing ultra-spectral protection
DE69627464T2 (en) Photostable, emulsifier-free, cosmetic products
EP0680746B1 (en) Sunscreen composition
DE60126303T2 (en) SUN PROTECTION MILK
DE19545789C2 (en) Use of isoalkanoic acids
EP1030649B1 (en) Light stable cosmetic formulation containing butylmethoxydibenzoylmethane
EP0876136B1 (en) Stable cosmetic and dermatological light-protecting preparations in the form of water/oil emulsions containing inorganic micro-pigments, derivatives of triazine and/or other components
EP0691126A1 (en) Cosmetic or dermatological compositions containing alpha hydroxy carboxylic acids and/or keto carboxylic acids and inorganic pigments
DE10200657A1 (en) 2: 1 complex of beta or gamma cyclodextrin and alpha tocopherol
EP0965325A2 (en) Dispersion of inorganic UV filter
EP0786246B1 (en) Cosmetic and dermatological sunscreen formulations containing triazine derivatives and polyglyceryl-2-polyhydroxystearate
EP0875240A2 (en) Combinations or complexes of derivatives of dibenzoymethane and/or derivatives of cinnamic acid with cyclodextrins and use of the combinations in cosmetic sun protecting compositions
EP1022017B1 (en) Cosmetic or pharmaceutical compositions for topical administration with improved stability
DE19856947B4 (en) Sunscreens and process for its preparation
CH684387A5 (en) Cosmetic or pharmaceutical product for topical application to the skin and the mucous membranes
EP1102576B1 (en) pH-STABILIZED ZnO IN SUNSCREEN FORMULATIONS
EP0995429A1 (en) Use of silicone surfactants and other surfactants for increasing the light protectionfactor and/or the UV-A-protection of cosmetic or dermatologic light protection agents
WO2005094769A1 (en) Cosmetic or dermatological preparations containing a mixture of a uv-a filter, a uv-b filter, and a metal oxide
WO2005025530A1 (en) Powdery preparations containing 2.4.6-trianilino-p-(carbo-2&#39;-ethylhexyl-1&#39;-oxi)-1.3.5-triazine
DE19820827A1 (en) Ultraviolet B filter combination used in cosmetic or dermatological formulation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAX Requested extension states of the european patent have changed

Free format text: LT PAYMENT 950510;SI PAYMENT 950510

17P Request for examination filed

Effective date: 19960508

17Q First examination report despatched

Effective date: 19990319

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SPIRIG PHARMA AG

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: LT PAYMENT 19950510;SI PAYMENT 19950510

LTIE Lt: invalidation of european patent or patent extension
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20011024

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRE;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.SCRIBED TIME-LIMIT

Effective date: 20011024

Ref country code: IE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20011024

REF Corresponds to:

Ref document number: 207340

Country of ref document: AT

Date of ref document: 20011115

Kind code of ref document: T

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: GERMAN

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: BRAUN & PARTNER PATENT-, MARKEN-, RECHTSANWAELTE

REF Corresponds to:

Ref document number: 59509732

Country of ref document: DE

Date of ref document: 20011129

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

ET Fr: translation filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20020124

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20020124

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20020124

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20020125

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 20020105

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20020430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020504

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020504

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020504

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020531

REG Reference to a national code

Ref country code: IE

Ref legal event code: FD4D

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20020504

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030131

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20040511

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20040527

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20040727

Year of fee payment: 10

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050504

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050531

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20051201

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL